Your browser is no longer supported. Please, upgrade your browser.
IMMU Immunomedics, Inc. daily Stock Chart
IMMU [NASD]
Immunomedics, Inc.
Index- P/E- EPS (ttm)-1.51 Insider Own7.19% Shs Outstand208.91M Perf Week0.39%
Market Cap4.32B Forward P/E- EPS next Y-1.61 Insider Trans56.52% Shs Float189.78M Perf Month19.20%
Income-351.10M PEG- EPS next Q-0.47 Inst Own80.20% Short Float15.41% Perf Quarter19.34%
Sales-0.87M P/S- EPS this Y53.10% Inst Trans-5.11% Short Ratio12.41 Perf Half Y58.39%
Book/sh0.13 P/B159.00 EPS next Y11.00% ROA-73.80% Target Price26.10 Perf Year8.22%
Cash/sh1.77 P/C11.69 EPS next 5Y- ROE-238.30% 52W Range11.55 - 21.50 Perf YTD44.85%
Dividend- P/FCF- EPS past 5Y-14.80% ROI- 52W High-3.86% Beta2.17
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low78.96% ATR0.88
Employees346 Current Ratio6.50 Sales Q/Q- Oper. Margin- RSI (14)70.46 Volatility4.21% 4.50%
OptionableYes Debt/Eq0.29 EPS Q/Q-43.10% Profit Margin- Rel Volume0.67 Prev Close20.73
ShortableYes LT Debt/Eq0.29 EarningsJan 29 AMC Payout- Avg Volume2.36M Price20.67
Recom2.00 SMA208.60% SMA5020.83% SMA20031.54% Volume1,579,968 Change-0.29%
Aug-08-19Reiterated H.C. Wainwright Buy $28 → $26
Mar-27-19Initiated Berenberg Buy $40
Mar-04-19Initiated H.C. Wainwright Buy $28
Jan-18-19Downgrade Wells Fargo Outperform → Market Perform
Nov-08-18Resumed Jefferies Buy
Nov-05-18Initiated Morgan Stanley Overweight
Oct-19-18Initiated Piper Jaffray Overweight
Sep-17-18Initiated Goldman Buy $36
Jun-07-18Initiated B. Riley FBR, Inc. Buy $53
May-05-17Upgrade Wells Fargo Market Perform → Outperform
Oct-06-16Resumed Jefferies Buy
Jun-21-16Downgrade Wells Fargo Outperform → Market Perform
May-06-16Upgrade Jefferies Hold → Buy
Dec-04-15Downgrade Wells Fargo Outperform → Market Perform
Jul-29-15Downgrade Jefferies Buy → Hold
Aug-27-14Downgrade R. F. Lafferty Buy → Neutral $4
Jan-08-14Initiated Chardan Capital Markets Buy $9
Oct-02-13Reiterated Oppenheimer Outperform $6 → $8
Sep-10-13Initiated R. F. Lafferty Buy $8
Jun-03-13Initiated WallachBeth Buy $6
Dec-14-19 07:30AM  Surging Biotech Stocks Kodiak Sciences, Immunomedics See Largest Holders Buy More Barrons.com
Dec-12-19 08:50AM  Are Options Traders Betting on a Big Move in Immunomedics (IMMU) Stock? Zacks
Dec-10-19 02:30PM  Signal Says Drug Stock Not Done Climbing Schaeffer's Investment Research
Dec-09-19 04:01PM  Immunomedics Announces Closing of Public Offering of Common Stock GlobeNewswire
Dec-08-19 07:27PM  Did Hedge Funds Drop The Ball On Immunomedics, Inc. (IMMU) ? Insider Monkey
Dec-04-19 08:29PM  Immunomedics Announces Pricing of Public Offering of Common Stock GlobeNewswire -5.21%
10:41AM  Immunomedics Resubmits Application for Breast Cancer Drug Zacks
07:06AM  The Daily Biotech Pulse: Roche's Tecentriq Snags FDA Nod For Lung Cancer, Rapt Out-Licenses Cancer Drug Benzinga
Dec-03-19 04:01PM  Immunomedics Announces Proposed Public Offering of Common Stock GlobeNewswire
08:00AM  Immunomedics Resubmits Biologics License Application to the FDA for Sacituzumab Govitecan GlobeNewswire
Nov-26-19 12:15PM  Implied Volatility Surging for Immunomedics (IMMU) Stock Options Zacks
Nov-24-19 04:19PM  The Week Ahead In Biotech: Aquestive Awaits FDA Decision, Arrowhead Earnings And More Benzinga
Nov-13-19 08:00AM  Immunomedics to Present at Upcoming Healthcare Conferences GlobeNewswire
Nov-08-19 09:32AM  Clovis (CLVS) Q3 Earnings & Sales Beat Estimates, Shares Up Zacks
Oct-31-19 06:53PM  Edited Transcript of IMMU earnings conference call or presentation 30-Oct-19 9:00pm GMT Thomson Reuters StreetEvents
12:40PM  Immunomedics (IMMU) Reports Wider-Than-Expected Loss in Q3 Zacks
Oct-30-19 04:00PM  Immunomedics Reports Third Quarter 2019 Results and Provides Corporate Update GlobeNewswire
Oct-28-19 11:18AM  3 Perfect 10 Biotech Stocks to Buy Amid Volatile Market Environment TipRanks
Oct-23-19 07:41PM  Hedge Funds Dont Love Immunomedics, Inc. (IMMU) Anymore Insider Monkey
04:27PM  Biotech Stock On The Radar: Immunomedics' Long Wait For Redemption Benzinga
08:00AM  Immunomedics to Report Third Quarter 2019 Results and Host Conference Call and Webcast on October 30, 2019 GlobeNewswire
Oct-13-19 04:25PM  Top Insider Buys Highlight for the Week of Oct. 11 GuruFocus.com
Oct-09-19 02:40AM  SHAREHOLDER REMINDER: Immunomedics, Inc. (IMMU) Sued for Misleading Shareholders; The Law Offices of Timothy L. Miles Encourages Immunomedics Shareholders to Contact the Firm ACCESSWIRE
Oct-06-19 05:27PM  Notable Insider Buys In The Past Week: Immunomedics, Tenet Healthcare, Ulta Beauty Benzinga
Oct-05-19 08:26AM  Trade Alert: The Of Immunomedics, Inc. (NASDAQ:IMMU), Bryan Ball, Has Just Spent US$71k Buying Shares Simply Wall St.
Oct-04-19 10:00PM  Bragar Eagel & Squire is Investigating Certain Officers and Directors of Healthcare Services Group, Heron Therapeutics, Immunomedics, and Karyopharm and Encourages Investors to Contact the Firm GlobeNewswire
Oct-01-19 04:42PM  Immunomedics (IMMU) Reports Interim Urothelial Cancer Data Zacks
08:00AM  Immunomedics to Present at the 2019 Cantor Global Healthcare Conference GlobeNewswire
Sep-30-19 04:31PM  Why This Biotech Stock Just Broke Out In Bullish Volume And Another Toppled Investor's Business Daily -7.40%
02:07PM  Seattle Genetics, Merck, Bristol-Myers Unveil Upbeat Treatment Data at Cancer Conference Barrons.com
01:13PM  Movers And Shakers At ESMO 2019: Immunomedics, G1 Therapeutics, Seattle Genetics And More Benzinga
12:05PM  A Look At Benzinga Pro's Most-Searched Tickers For September 30, 2019 Benzinga
11:56AM  Call Traders Eye Biotech Stock's Big Drop Schaeffer's Investment Research
09:15AM  Seattle Genetics Climbs on Positive Trial Results for Bladder Cancer Treatment TheStreet.com
08:33AM  Immunomedics Stock Drops After Bladder-Cancer-Drug Results Disappoint TheStreet.com
Sep-28-19 12:30PM  Immunomedics Provides Corporate Update GlobeNewswire
Sep-24-19 02:55AM  SHAREHOLDER REMINDER: Immunomedics, Inc. (IMMU) Sued for Misleading Shareholders; The Law Offices of Timothy L. Miles Encourages Immunomedics Shareholders to Contact the Firm ACCESSWIRE -6.62%
Sep-16-19 05:40PM  SHAREHOLDER ALERT: Immunomedics, Inc. (IMMU) Sued for Misleading Shareholders; The Law Offices of Timothy L. Miles Encourages Immunomedics Shareholders to Contact the Firm ACCESSWIRE
Sep-12-19 08:35AM  Immunomedics (IMMU) Looks Good: Stock Adds 6.1% in Session Zacks
08:00AM  Immunomedics to Host Investor Event and Webcast on September 28, 2019 During ESMO Congress GlobeNewswire
Sep-06-19 09:31AM  Why Is Immunomedics (IMMU) Down 13.1% Since Last Earnings Report? Zacks
Sep-05-19 07:53PM  Bragar Eagel & Squire is Investigating Certain Officers and Directors of MGT Capital Investments, First American Financial, Immunomedics, and AAC Holdings and Encourages Investors to Contact the Firm GlobeNewswire
Sep-04-19 07:45AM  Immunomedics Announces Oral Presentation of Sacituzumab Govitecan in Metastatic Urothelial Cancer at ESMO 2019 Annual Congress GlobeNewswire +6.99%
Sep-03-19 02:58PM  Shareholder Alert: Robbins Arroyo LLP Reminds Investors Immunomedics, Inc. (IMMU) Sued for Misleading Shareholders Business Wire
Aug-28-19 08:00AM  Immunomedics to Participate in Upcoming Healthcare Conferences GlobeNewswire
Aug-08-19 06:27PM  Immunomedics, Inc. (IMMU) Q2 2019 Earnings Call Transcript Motley Fool +5.20%
04:46PM  Edited Transcript of IMMU earnings conference call or presentation 7-Aug-19 9:00pm GMT Thomson Reuters StreetEvents
10:45AM  Immunomedics (IMMU) Posts Wider-Than-Expected Loss in Q2 Zacks
Aug-07-19 04:00PM  Immunomedics Reports Second Quarter 2019 Results and Provides Corporate Update GlobeNewswire
Aug-01-19 08:00AM  Immunomedics to Report Second Quarter 2019 Results and Host Conference Call and Webcast on August 7, 2019 GlobeNewswire
Jul-23-19 11:46AM  Drug Stock With Cheap Options Sounds Bear Signal Schaeffer's Investment Research
Jul-04-19 11:01AM  3 Hot Insider Trading Stocks To Boost Your Portfolio TipRanks
Jul-03-19 01:17PM  Are Insiders Buying Immunomedics, Inc. (NASDAQ:IMMU) Stock? Simply Wall St. +5.21%
Jun-30-19 10:09AM  Notable Insider Buys This Past Week: AbbVie, MGM and More Benzinga
Jun-09-19 04:28PM  Notable Insider Buys This Past Week: American Airlines, MGM and More Benzinga
May-29-19 08:00AM  Immunomedics to Participate in Upcoming Healthcare Conferences GlobeNewswire
May-20-19 08:41AM  2 Biotech Names See Directors Direct Cash to Their Shares TheStreet.com
May-14-19 09:07PM  Edited Transcript of IMMU earnings conference call or presentation 9-May-19 12:00pm GMT Thomson Reuters StreetEvents
May-09-19 07:40AM  Immunomedics: 1Q Earnings Snapshot Associated Press
07:00AM  Immunomedics Reports First Quarter 2019 Results and Provides Corporate Update GlobeNewswire
May-07-19 08:00AM  Immunomedics To Participate In Upcoming Healthcare Conferences GlobeNewswire
May-02-19 08:00AM  Immunomedics to Report First Quarter 2019 Results and Host Conference Call and Webcast on May 9, 2019 GlobeNewswire
Apr-29-19 12:46PM  Stocks making the biggest moves midday: Disney, Restaurant Brands, Gardner Denver, Target & more CNBC -5.39%
07:40AM  Immunomedics and Everest Medicines Announce Exclusive License Agreement for Sacituzumab Govitecan in East and Southeast Asia Excluding Japan GlobeNewswire
07:35AM  Immunomedics Announces Departure of Chief Medical Officer GlobeNewswire
Apr-26-19 01:11PM  Seattle Genetics (SGEN) Q1 Loss Narrows, Revenues Top Mark Zacks
12:07PM  Is Immunomedics, Inc. (IMMU) A Good Stock To Buy? Insider Monkey
07:17AM  Is Immunomedics, Inc. (NASDAQ:IMMU) Trading At A 34% Discount? Simply Wall St.
Apr-08-19 09:00AM  Immunomedics Announces Promotion Agreement With Janssen for Erdafitinib in the U.S. GlobeNewswire
Mar-07-19 04:01PM  Immunomedics Appoints Barbara G. Duncan to Board of Directors GlobeNewswire
Mar-04-19 08:00AM  Immunomedics to Participate in Cowen and Company 39th Annual Health Care Conference GlobeNewswire
Mar-01-19 08:35AM  Research Report Identifies Axalta Coating, The Home Depot, Immunomedics, Kosmos Energy, Casa, and Ormat Technologies with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire +5.01%
07:51AM  Edited Transcript of IMMU earnings conference call or presentation 25-Feb-19 10:00pm GMT Thomson Reuters StreetEvents
Feb-26-19 08:30AM  Lawsuit for Investors in NASDAQ: IMMU shares against Immunomedics, Inc. announced by Shareholders Foundation GlobeNewswire +6.98%
07:56AM  The Daily Biotech Pulse: Immunomedics CEO Departs, Ultragenyx Offering, Karyopharm Awaits FDA Panel Vote Benzinga
07:05AM  Immunomedics Inc (IMMU) Q4 2018 Earnings Conference Call Transcript Motley Fool
Feb-25-19 05:54PM  CLASS ACTION UPDATE for IMMU, ALKS and SVXY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
04:01PM  Immunomedics Reports Results For Period Ended December 31, 2018, Strengthens Board And Announces Senior Leadership Changes GlobeNewswire
03:45PM  DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Stockholders of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline- February 25, 2019 ACCESSWIRE
03:16PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of DNKEY, IMMU, PRGO and DXC GlobeNewswire
02:19PM  CLASS ACTION UPDATE for IMMU, DXC and W: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
12:44PM  DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline- February 25, 2019 ACCESSWIRE
12:30PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of IMMU, YRIV, MAXR and SVXY GlobeNewswire
10:43AM  DEADLINE ALERT - IMMU, ALKS & DXC - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
Feb-24-19 10:50PM  IMMUNOMEDICS 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Immunomedics, Inc. - IMMU Business Wire
06:06PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DXC Technology, Immunomedics, Natural Health, and Maiden Holdings and Encourages Investors to Contact the Firm GlobeNewswire
02:24PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunomedics, Inc. of Class Action Lawsuit and Upcoming Deadline IMMU ACCESSWIRE
01:57PM  CLASS ACTION UPDATE for SOGO, IMMU, W and AVP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
01:42PM  DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline- February 25, 2019 ACCESSWIRE
11:40AM  IMMU, ALKS & DXC - Bronstein, Gewirtz & Grossman, LLC Class Action Update ACCESSWIRE
10:55AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ARLO, IMMU, MKL and SVXY GlobeNewswire
Feb-22-19 10:50PM  Immunomedics 72 Hour Deadline Alert: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Immunomedics, Inc. - IMMU Business Wire
05:27PM  CLASS ACTION UPDATE for IMMU, GSM, TYME and GE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
03:52PM  DEADLINE ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline - February 25, 2019 ACCESSWIRE
01:54PM  CLASS ACTION UPDATE for YRCW, IMMU, MKL and MAXR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
01:07PM  Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Immunomedics, Inc. GlobeNewswire
12:51PM  DEADLINE ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline: February 25, 2019 ACCESSWIRE
12:35PM  DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunomedics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
11:13AM  CLASS ACTION UPDATE for IMMU, ALKS, UXIN and AVP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:00AM  Immunomedics, Inc. (IMMU), Alkermes plc, Inc. (ALKS) & DXC Technology Company (DXC) - Bronstein, Gewirtz & Grossman, LLC Class Action Update ACCESSWIRE
Immunomedics, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibody-based products for the targeted treatment of cancer. Its advanced antibody-drug conjugates are sacituzumab govitecan and labetuzumab govitecan, which are in advanced trials for various solid tumors and metastatic colorectal cancer, respectively. The company focuses on commercializing sacituzumab govitecan as a third-line therapy for patients with metastatic triple-negative breast cancer in the United States. The company also develops IMMU-140, a humanized antibody directed against an immune response target. Its other product candidates include products for the treatment of cancer and autoimmune diseases, including epratuzumab, an anti-CD22 antibody; veltuzumab, an anti-CD20 antibody; milatuzumab, an anti-CD74 antibody; and IMMU-114, a humanized anti-HLA-DR antibody. Immunomedics, Inc. has clinical collaboration with AstraZeneca and MedImmune, to evaluate Imfinzi, a human monoclonal antibody against PD-L1, with sacituzumab govitecan as a frontline treatment of patients with TNBC and urothelial cancer; collaboration agreement with The Bayer Group for the development of epratuzumab; clinical and preclinical collaborations with academic cancer institutions, identifying new cancer indications for sacituzumab govitecan and the biology of the Trop-2 antigen; and research collaboration with the Memorial Sloan Kettering Cancer Center to investigate Sacituzumab Govitecan and Labetuzumab Govitecan in preclinical cancer models. Immunomedics, Inc. has a partnership agreement with the Samsung BioLogics Co., Ltd. to manufacture hRS7, an Immunomedics proprietary humanized antibody; and a collaboration and license agreement with pH Pharma Co. Ltd. for the development and commercialization of multiple novel antibody-drug conjugates in oncology. The company was founded in 1982 and is headquartered in Morris Plains, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Avoro Capital Advisors LLCDirectorDec 05Buy17.502,000,00035,000,00024,500,000Dec 09 04:05 PM
Avoro Capital Advisors LLCDirectorOct 03Buy14.10500,0007,050,00022,500,000Oct 04 09:50 AM
BALL BRYANChief Quality OfficerOct 03Buy14.185,00070,89710,000Oct 03 05:30 PM
Avoro Capital Advisors LLCDirectorOct 02Buy13.231,000,00013,230,00022,000,000Oct 04 09:50 AM
Avoro Capital Advisors LLCDirectorJun 28Buy13.84250,0003,460,00021,000,000Jun 28 05:13 PM
Avoro Capital Advisors LLCDirectorJun 27Buy13.68350,0004,788,00020,750,000Jun 28 05:13 PM
Avoro Capital Advisors LLCDirectorJun 26Buy13.25400,0005,300,00020,400,000Jun 28 05:13 PM
BALL BRYANChief Quality OfficerJun 20Buy13.355,00066,7505,000Jun 21 08:47 AM
Avoro Capital Advisors LLCDirectorJun 05Buy12.47250,0003,117,50020,000,000Jun 05 11:42 AM
Avoro Capital Advisors LLCDirectorJun 04Buy12.10500,0006,050,00019,750,000Jun 05 11:42 AM
Avoro Capital Advisors LLCDirectorJun 03Buy12.19785,5399,575,72019,250,000Jun 05 11:42 AM
Avoro Capital Advisors LLCDirectorMay 15Buy14.95125,0001,868,75018,464,461May 15 05:25 PM
Avoro Capital Advisors LLCDirectorMay 14Buy15.40125,0001,925,00018,339,461May 15 05:25 PM
Avoro Capital Advisors LLCDirectorMay 13Buy15.07500,0007,535,00018,214,461May 15 05:25 PM